Search
for
Sort by
Research 511–540 of 1000+
- Topical Finasteride versus Topical Spironolactone in the Treatment of Androgenetic Alopecia
- A randomised trial of 5% minoxidil versus combination of 5% minoxidil and oral spironolactone in treatment of female pattern hair loss
- Metoprolol-spironolactone combination for coronary heart disease with concurrent heart failure: impact on cardiac function
- Finasteride/spironolactone
- The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial
- 15809 Spironolactone use does not increase the risk of estrogen-dependent cancer recurrence: A retrospective analysis
- Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial
- Therapeutic Evaluation of Spironolactone and Finasteride in the Treatment of Acne Vulgaris
- Use of Finasteride and Spironolactone in Hospitalized COVID-19 Patients and Their Effect on Severity Outcomes
- Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent females / supplemental files
- Hair Sciences: Comments on the use of spironolactone in female pattern hair loss
- Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)
- Simultaneous Versus Delayed Initiation of Spironolactone and Low‐Dose Oral Minoxidil: Adverse Event Rates in a Retrospective Cohort Study
- Evaluation of the efficacy of topical spironolactone 5% solution versus minoxidil 5% solution vs combination of topical spironolactone 5% and minoxidil 5% solutions in female pattern hair loss
- ISID0503 – Use of low-dose spironolactone in female pattern hair loss in a specialty alopecia clinic
- Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats
- Comparative study between topical minoxidil 5% and oral spironolactone versus topical minoxidil 5% and oral dutasteride in the treatment of women with androgenic alopecia
- Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study
- Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study
- A Review of the Efficacy and Safety Profile of Oral Spironolactone Use for Androgenic Alopecia -Supplemental Text
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- Sexual Hormones in Human Skin
- Bioavailability of Albumin-Bound Testosterone†
- Medical treatments for male and female pattern hair loss
- The Human Sebocyte Culture Model Provides New Insights into Development and Management of Seborrhoea and Acne
- Hirsutism and acne in polycystic ovary syndrome
- Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Treatment of hirsutism with the pure antiandrogen flutamide
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Androgenetic Alopecia: An Update of Treatment Options